Featured Research

from universities, journals, and other organizations

Penn Researchers To Study Treatment Options For "Eye Attacks"

Date:
January 12, 2001
Source:
University Of Pennsylvania Medical Center
Summary:
The terms “heart attack” and “brain attack” have become commonplace, but now neuro-ophthalmologists are waging war on the all too common, underreported, and untreated condition referred to as “eye attacks.” These attacks, known medically as Ischematic Optic Neuropathy (“ION”), result from a sudden lack of blood flow to the eye. Eye attacks, which are usually painless, can develop quite rapidly--sometimes overnight, often with catastrophic consequences to the vision of the individual, such as a sudden and permanent loss of peripheral or central vision in one eye.

The terms “heart attack” and “brain attack” have become commonplace, but now neuro-ophthalmologists are waging war on the all too common, underreported, and untreated condition referred to as “eye attacks.” These attacks, known medically as Ischematic Optic Neuropathy (“ION”), result from a sudden lack of blood flow to the eye. Eye attacks, which are usually painless, can develop quite rapidly--sometimes overnight, often with catastrophic consequences to the vision of the individual, such as a sudden and permanent loss of peripheral or central vision in one eye. The resulting visual impairment and the degree of severity usually varies from patient to patient but can include loss of the bottom half of one’s vision and difficulty with light and darkness.

Related Articles


University of Pennsylvania Medical Center researchers are working to help educate the public about this condition, which is the most common cause of acute optical nerve disease in adults over 50 years of age. While the frequency of the condition is estimated to occur in only a couple of people per thousand, per year, the catastrophic results are unquestioned. Studies indicate that irreversible damage can occur as quickly as within the first 90 seconds of the attack. “Prompt acknowledgement and treatment of the problem are essential if there is any chance of minimizing present and future damage”, says neuro-ophthalmologist and researcher Nicholas J. Volpe MD, Associate Professor of Ophthalmology & Neurology at the University of Pennsylvania’s Scheie Eye Institute. However, a new multi-center clinical trial, funded by the pharmaceutical company Allergan, is about to commence at approximately 50 research sites across the country, including the Scheie Eye Institute. The goal of the study is to determine whether neuro-protection-- i.e., delivering a proprietary and investigational topical agent to help a damaged nerve-- is viable. Specifically, Allergan is testing eye drops that will hopefully minimize collateral losses to the eye by saving some of the optic nerve fibers.

Contributing to the sense of urgency in promoting public awareness is the fact that most sufferers do not come forward and report the condition-- believing it, instead, to be a problem with their glasses or just a temporary, passing phase. This failure in reporting is critical, as researchers have been hampered by limited access to affected persons in a timely manner. Early reporting is essential as evidence now suggests that measures designed to limit further damage are most likely to succeed if intervention occurs within the first several hours. In addition, evidence exists that an attack in the other eye occurs up to 15 % of the time, over the following five years. Currently, a daily dose of aspirin is the only treatment offered, having a potential prophylactic effect on the second eye. Eye attacks, which are not a new occurrence, have been treated over the years by using steroids and surgical intervention--neither with much success. A visual problem that typically occurs later in life as part of the aging process, “ION” is also suspected to occur with increased frequency in patients with diabetes and hypertension, in addition to occurring frequently in people with small, crowded optic nerves. At this time, little can be done for the damaged eye, therefore successful prevention of second eye involvement is another goal of new research studies. A secondary and independent research study is also being performed by Volpe in conjunction with Carolyn Glazer, MD and Juan Grunwald MD, a retinal blood flow expert, also with Penn’s Scheie Eye Institute. This study will attempt to focus on the characteristics and nature of the blood flow patterns in a patient’s healthy eye, once he or she has suffered an eye attack. By examining the characteristics of the optic nerve in the healthy eye, the researchers hope to develop treatment strategies that can be used to protect the second eye.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Penn Researchers To Study Treatment Options For "Eye Attacks"." ScienceDaily. ScienceDaily, 12 January 2001. <www.sciencedaily.com/releases/2001/01/010111073731.htm>.
University Of Pennsylvania Medical Center. (2001, January 12). Penn Researchers To Study Treatment Options For "Eye Attacks". ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2001/01/010111073731.htm
University Of Pennsylvania Medical Center. "Penn Researchers To Study Treatment Options For "Eye Attacks"." ScienceDaily. www.sciencedaily.com/releases/2001/01/010111073731.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins